CDD3506 is used for elevating high density lipoprotein cholesterol (HDL) by inducing hepatic cytochrome P450IIIA (CYP3A) activity.
CDD3506 specifically induces hepatic cytochrome P450IIIA produces significant increases in HDL cholesterol[1].
[1]. Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes. United States Patent 6103733
















